EIT Health announces HICEE Project for Start-ups

This programme is looking for promising ventures in life sciences such as biotech, medtech, and digital health. Up to 25 ventures, including both early-stage start-ups (pre-seed or seed) and local rising stars (Series A and beyond), will be selected for extensive training.

Selected start-ups will receive tailored investment readiness support to make them attractive co-investment targets, connecting them with a wider investor community and creating opportunities to extend their runways.

Key Benefits for Participants

• Access to influential stakeholders in CEE, including investors, support organisations, universities, and public bodies.
• Tailored support and training are provided through customised programmes that meet the unique needs of each start-up. They will be able to choose from a range of customisable support services tailored to their requirements and be eligible for specialised financial support through the EIT Health Accelerator Access to Finance services.
• Participants benefit from being recognised as top emerging start-ups, gaining visibility and access to exclusive events and channels that enhance their profiles.

Criteria

The HICEE project is open to CEE start-ups that meet the following criteria:

• Small and Medium-sized Enterprises (SMEs) according to EU definition (Commission Recommendation 2003/361/EC).
• Legally established in one of the Horizon Europe countries (Member States and eligible non-EU countries).
• Registered in Central and Eastern Europe with headquarters or offices in CEE.
• Intending to grow in Europe.
• Engaged in life sciences innovation in biotech, MedTech, and digital health.
• Possessing a disruptive, innovative solution.
• Having international ambitions and high growth potential.
• Owning or having rights to the intellectual property that is the basis for the project or product.

For more information, visit EIT Health.